Revisions for Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) | Registro Público Cubano de Ensayos Clínicos

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) has 2 revisions.

Revision		Status
Saved 19/07/2023 - 2:22pm by Gladys		current revision (published)
Saved 28/12/2018 - 10:16am by Gladys		archived

Registered Trials

Registration process

About the RPCEC

Useful resources